Home » Topics » BioWorld Science

BioWorld Science
RSS

SKB to begin pivotal trials with antibody for RA

Nov. 22, 1996

IDEC to present final pivotal data on IDEC-C2B8

Nov. 22, 1996

Chiroscience to acquire U.S. gene-based biotech company

Nov. 22, 1996

Cortecs plans oral insulin studies in diabetic patients

Nov. 22, 1996

Cytel/Abbott collaboration reaches milestone

Nov. 22, 1996

FDA issues approvable letter for Nycomed diagnostic

Nov. 22, 1996

Favorable phase I results reported for NC-100100

Nov. 22, 1996

OraVax, bioMerieux licensing agreement for H. pylori diagnostic technology

Nov. 22, 1996

PDL anti-HBV antibody enters phase II

Nov. 22, 1996

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...